A detailed history of Connecticut Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Connecticut Wealth Management, LLC holds 3,654 shares of ABBV stock, worth $657,720. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,654
Previous 2,162 69.01%
Holding current value
$657,720
Previous $370,000 94.86%
% of portfolio
0.04%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $244,449 - $297,400
1,492 Added 69.01%
3,654 $721,000
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $28,481 - $33,259
184 Added 9.3%
2,162 $370,000
Q1 2024

May 01, 2024

SELL
$159.82 - $182.1 $5,593 - $6,373
-35 Reduced 1.74%
1,978 $360,000
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $34,124 - $38,432
248 Added 14.05%
2,013 $311,000
Q3 2023

Oct 19, 2023

BUY
$133.59 - $154.65 $26,718 - $30,930
200 Added 12.78%
1,765 $263,000
Q2 2023

Jul 25, 2023

SELL
$132.51 - $164.9 $1,325 - $1,649
-10 Reduced 0.63%
1,565 $210,000
Q1 2023

Apr 18, 2023

BUY
$144.61 - $166.54 $227,760 - $262,300
1,575 New
1,575 $251,000
Q2 2021

Jul 29, 2021

SELL
$105.21 - $117.21 $271,441 - $302,401
-2,580 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$102.3 - $112.62 $123,066 - $135,481
-1,203 Reduced 31.8%
2,580 $279,000
Q1 2021

Apr 29, 2021

BUY
$102.3 - $112.62 $123,271 - $135,707
1,205 Added 46.74%
3,783 $343,000
Q4 2020

Jan 29, 2021

BUY
$80.49 - $108.67 $160 - $217
2 Added 0.08%
2,578 $276,000
Q3 2020

Oct 13, 2020

BUY
$85.91 - $100.83 $221,304 - $259,738
2,576 New
2,576 $226,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Connecticut Wealth Management, LLC Portfolio

Follow Connecticut Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connecticut Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connecticut Wealth Management, LLC with notifications on news.